Dr Elizabeth D Barot, MD | |
Myrah Keating Smith Community Health Center, St. John, VI 00831 | |
(340) 693-8900 | |
(340) 693-9506 |
Full Name | Dr Elizabeth D Barot |
---|---|
Gender | Female |
Speciality | Emergency Medicine |
Experience | 51 Years |
Location | Myrah Keating Smith Community Health Center, St. John, Virgin Island |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1568574424 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 754 (Virgin Island) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Myrah Keating Smith Community Health Center | 0244216638 | 2 |
News Archive
With the debt-ceiling looming and other divisive budget issues on the table, some Republican lawmakers appeared to back away from their plan to "voucherize" Medicare.
Kootenai Health and Mayo Clinic leaders today announced Kootenai Health as a member of the Mayo Clinic Care Network, a national network of like-minded organizations that share a commitment to better serving patients and their families.
NuPathe Inc., a specialty pharmaceutical company developing innovative products for the treatment of neurological and psychiatric diseases, today announced data from the pivotal Phase III trial of Zelrix™, a novel transdermal patch in clinical development for the treatment of acute migraine. Zelrix combines NuPathe's proprietary SmartRelief™ iontophoretic transdermal technology with sumatriptan, the most prescribed treatment for acute migraine in the United States.
A new study involving The University of Queensland, which might be useful for biomedical research, re-writes parts of the rulebook on how mammalian brains - including our own - could have evolved.
› Verified 3 days ago
Entity Name | Vi Government Hospital And Health Facilities Corp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1487699047 PECOS PAC ID: 6204722879 Enrollment ID: O20040223000586 |
News Archive
With the debt-ceiling looming and other divisive budget issues on the table, some Republican lawmakers appeared to back away from their plan to "voucherize" Medicare.
Kootenai Health and Mayo Clinic leaders today announced Kootenai Health as a member of the Mayo Clinic Care Network, a national network of like-minded organizations that share a commitment to better serving patients and their families.
NuPathe Inc., a specialty pharmaceutical company developing innovative products for the treatment of neurological and psychiatric diseases, today announced data from the pivotal Phase III trial of Zelrix™, a novel transdermal patch in clinical development for the treatment of acute migraine. Zelrix combines NuPathe's proprietary SmartRelief™ iontophoretic transdermal technology with sumatriptan, the most prescribed treatment for acute migraine in the United States.
A new study involving The University of Queensland, which might be useful for biomedical research, re-writes parts of the rulebook on how mammalian brains - including our own - could have evolved.
› Verified 3 days ago
Entity Name | Myrah Keating Smith Community Health Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1144250580 PECOS PAC ID: 0244216638 Enrollment ID: O20050524000755 |
News Archive
With the debt-ceiling looming and other divisive budget issues on the table, some Republican lawmakers appeared to back away from their plan to "voucherize" Medicare.
Kootenai Health and Mayo Clinic leaders today announced Kootenai Health as a member of the Mayo Clinic Care Network, a national network of like-minded organizations that share a commitment to better serving patients and their families.
NuPathe Inc., a specialty pharmaceutical company developing innovative products for the treatment of neurological and psychiatric diseases, today announced data from the pivotal Phase III trial of Zelrix™, a novel transdermal patch in clinical development for the treatment of acute migraine. Zelrix combines NuPathe's proprietary SmartRelief™ iontophoretic transdermal technology with sumatriptan, the most prescribed treatment for acute migraine in the United States.
A new study involving The University of Queensland, which might be useful for biomedical research, re-writes parts of the rulebook on how mammalian brains - including our own - could have evolved.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Elizabeth D Barot, MD 11-4 Pastory, St. John, VI 00831 Ph: (340) 776-6400 | Dr Elizabeth D Barot, MD Myrah Keating Smith Community Health Center, St. John, VI 00831 Ph: (340) 693-8900 |
News Archive
With the debt-ceiling looming and other divisive budget issues on the table, some Republican lawmakers appeared to back away from their plan to "voucherize" Medicare.
Kootenai Health and Mayo Clinic leaders today announced Kootenai Health as a member of the Mayo Clinic Care Network, a national network of like-minded organizations that share a commitment to better serving patients and their families.
NuPathe Inc., a specialty pharmaceutical company developing innovative products for the treatment of neurological and psychiatric diseases, today announced data from the pivotal Phase III trial of Zelrix™, a novel transdermal patch in clinical development for the treatment of acute migraine. Zelrix combines NuPathe's proprietary SmartRelief™ iontophoretic transdermal technology with sumatriptan, the most prescribed treatment for acute migraine in the United States.
A new study involving The University of Queensland, which might be useful for biomedical research, re-writes parts of the rulebook on how mammalian brains - including our own - could have evolved.
› Verified 3 days ago